XTX Topco’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Buy
+34,796
New +$332K ﹤0.01% 2830
2026
Q1
Sell
-45,990
Closed -$342K 3873
2025
Q4
$342K Sell
45,990
-24,904
-35% -$179K 0.01% 1951
2025
Q3
$474K Buy
+70,894
New +$492K 0.02% 1116
2024
Q4
Sell
-37,734
Closed -$451K 2332
2024
Q3
$451K Sell
37,734
-3,426
-8% -$29.6K 0.03% 889
2024
Q2
$237K Buy
+41,160
New +$226K 0.02% 1112
2023
Q4
Sell
-13,212
Closed -$43.6K 1632
2023
Q3
$43.6K Buy
13,212
+1,182
+10% +$4.15K 0.01% 1291
2023
Q2
$34.8K Buy
+12,030
New +$23.1K 0.01% 1285
2023
Q1
Sell
-15,092
Closed -$39.4K 1295
2022
Q4
$39.4K Buy
+15,092
New +$65.9K 0.01% 1056

Other funds holding BVS

XTX Topco's BVS Position: Q2 2026 in Review

XTX Topco opened a new position in Bioventus (BVS) in Q2 2026: 34,796 shares worth $328K. The stake represents ﹤0.01% of the portfolio and ranks #2830 among its holdings. This is a return to the name: XTX Topco previously reported a position in BVS as recently as Q4 2025.

XTX Topco first reported a position in BVS in Q4 2022 and has held it in 8 quarters since. The position peaked at $474K in Q3 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • XTX Topco held 34,796 shares of Bioventus worth $328K as of Q2 2026.
  • Bioventus was a new XTX Topco position in Q2 2026.
  • Bioventus made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2830 holding.
  • XTX Topco first reported a position in Bioventus in Q4 2022 and has held it in 8 quarters since.
  • XTX Topco's Bioventus position peaked at $474K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.